Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
NCT03482479Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Feb 2019
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of naltrexone in vasculitis, sponsored by University of Pennsylvania. Started Feb 2019; status: completed.
02
Drugs
naltrexone
03
Conditions
vasculitis
Beyond the preview
Go deeper on NCT03482479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03482479.